Avalo Therapeutics Inc (AVTX)
11.94
+0.19
(+1.62%)
USD |
NASDAQ |
May 31, 16:00
11.50
-0.44
(-3.69%)
After-Hours: 20:00
Avalo Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | -2.025 |
March 31, 2023 | -3.154 |
December 31, 2022 | -1.779 |
September 30, 2022 | -9.401 |
June 30, 2022 | -3.144 |
March 31, 2022 | 5.231 |
December 31, 2021 | 1.422 |
September 30, 2021 | 0.8058 |
June 30, 2021 | 0.7941 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
Date | Value |
---|---|
December 31, 2019 | 0.00 |
September 30, 2019 | 0.8399 |
June 30, 2019 | 0.8662 |
March 31, 2019 | 0.6641 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.7895 |
June 30, 2018 | 0.8027 |
March 31, 2018 | 0.6255 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.1938 |
March 31, 2017 | -3.505 |
December 31, 2016 | 11.37 |
September 30, 2016 | 5.436 |
June 30, 2016 | 0.7184 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-9.401
Minimum
Sep 2022
5.231
Maximum
Mar 2022
-0.5023
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
Imunon Inc | -- |
iBio Inc | -- |
Kodiak Sciences Inc | -- |
Petros Pharmaceuticals Inc | 0.7494 |
Ocugen Inc | 0.0935 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 123.73M |
Total Liabilities (Quarterly) | 224.81M |
Shareholders Equity (Quarterly) | -101.08M |